Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 13/20 | 0.47 |
| ▸ | THRA | P10827 | 11/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 7/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7256540 | 0.79 | NR3C1 (0.55) | THRBTHRANR3C1 | |
| SCHEMBL7254383 | 0.76 | NR3C1 (0.47) | THRBTHRANR3C1 | |
| SCHEMBL7251353 | 0.75 | NR3C1 (0.47) | THRBTHRANR3C1 | |
| SCHEMBL7250255 | 0.73 | NR3C1 (0.44) | THRBTHRANR3C1 | |
| SCHEMBL7255680 | 0.73 | NR3C1 (0.57) | THRBTHRANR3C1 | |
| SCHEMBL7250218 | 0.72 | NR3C1 (0.59) | THRBTHRANR3C1 | |
| SCHEMBL5632436 | 0.72 | NR3C1 (0.65) | THRBTHRANR3C1 | |
| SCHEMBL4898133 | 0.71 | THRB (0.73) | THRBTHRA | |
| SCHEMBL4281916 | 0.70 | FOS (0.47) | — | |
| SCHEMBL7251065 | 0.69 | NR3C1 (0.55) | THRBTHRANR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030166725-A1 | Compounds active at the glucocorticoid receptor | KARO BIO AB (SE) | 2003-09-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166725-A1 | Compounds active at the glucocorticoid receptor | NR3C1, NR3C2, GPR119 | THRB 167/4885THRA 291/4885NR3C1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.